Dimensional Fund Advisors’s 4D Molecular Therapeutics FDMT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $208K | Sell |
55,937
-18,629
| -25% | -$69.2K | ﹤0.01% | 3111 |
|
|
2025
Q1 | $241K | Sell |
74,566
-57,399
| -43% | -$186K | ﹤0.01% | 3103 |
|
|
2024
Q4 | $735K | Sell |
131,965
-76,850
| -37% | -$428K | ﹤0.01% | 2975 |
|
|
2024
Q3 | $2.26M | Sell |
208,815
-323,927
| -61% | -$3.5M | ﹤0.01% | 2759 |
|
|
2024
Q2 | $11.2M | Sell |
532,742
-216,250
| -29% | -$4.54M | ﹤0.01% | 2214 |
|
|
2024
Q1 | $23.9M | Buy |
748,992
+54,099
| +8% | +$1.72M | 0.01% | 1892 |
|
|
2023
Q4 | $14.1M | Buy |
694,893
+24,294
| +4% | +$492K | ﹤0.01% | 2158 |
|
|
2023
Q3 | $8.54M | Buy |
670,599
+239,488
| +56% | +$3.05M | ﹤0.01% | 2339 |
|
|
2023
Q2 | $7.79M | Buy |
431,111
+284,153
| +193% | +$5.13M | ﹤0.01% | 2364 |
|
|
2023
Q1 | $2.53M | Buy |
+146,958
| New | +$2.53M | ﹤0.01% | 2678 |
|